Keystone Financial Planning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-92,448
Closed -$7.58M 49
2022
Q1
$7.58M Sell
92,448
-502
-0.5% -$39.6K 2.54% 13
2021
Q4
$7.12M Buy
92,950
+2,968
+3% +$236K 2.43% 16
2021
Q3
$6.76M Buy
89,982
+14,247
+19% +$1.08M 2.46% 13
2021
Q2
$5.89M Buy
+75,735
New +$5.63M 2.13% 17
2014
Q1
Sell
-734
Closed -$35K 73
2013
Q4
$35K Buy
+734
New +$33.6K 0.03% 65

Other funds holding MRK

Keystone Financial Planning's MRK Position: Q2 2022 in Review

Keystone Financial Planning sold out of Merck (MRK) in Q2 2022, closing a stake of 92,448 shares — an estimated $7.58M sold.

Keystone Financial Planning first reported a position in MRK in Q4 2013 and held it in 5 quarters. The position peaked at $7.58M in Q1 2022. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Keystone Financial Planning reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Keystone Financial Planning sold 92,448 Merck shares in Q2 2022, an estimated $7.58M.
  • Keystone Financial Planning first reported a position in Merck in Q4 2013 and held it in 5 quarters.
  • Keystone Financial Planning's Merck position peaked at $7.58M in Q1 2022.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Keystone Financial Planning's 13F filing for Q2 2022, filed 19 Jul 2022.